...
nvno-img

enVVeno Medical Corp, Common Stock

NVNO

NAQ

$2.49

-$0.04

(-1.58%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$44.37M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
687.07K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.22
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.45 L
$6.97 H
$2.49

About enVVeno Medical Corp, Common Stock

enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of venous Chronic Venous Insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg; and enVVe, a non-surgical, transcatheter based replacement venous valve for the treatment of CVI. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameNVNOSectorS&P500
1-Week Return-12.63%-2.12%-3%
1-Month Return-26.11%-3.42%-0.73%
3-Month Return-47.58%-11.13%2.87%
6-Month Return-46.68%-5.74%7.17%
1-Year Return-45.51%3.97%25.31%
3-Year Return-62.84%1.05%28.38%
5-Year Return-76.84%34.37%81.89%
10-Year Return-98.1%97.88%183.27%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue31.24K----[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue-383.97K452.91K525.00K546.00K[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":70.32,"profit":true},{"date":"2021-12-31","value":82.95,"profit":true},{"date":"2022-12-31","value":96.15,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit31.24K(383.97K)(452.91K)(525.00K)(546.00K)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-1228.99,"profit":false},{"date":"2021-12-31","value":-1449.63,"profit":false},{"date":"2022-12-31","value":-1680.38,"profit":false},{"date":"2023-12-31","value":-1747.59,"profit":false}]
Gross Margin100.00%(Infinity%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses7.12M9.14M16.89M24.93M25.24M[{"date":"2019-12-31","value":28.2,"profit":true},{"date":"2020-12-31","value":36.2,"profit":true},{"date":"2021-12-31","value":66.93,"profit":true},{"date":"2022-12-31","value":98.79,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(7.68M)(9.14M)(16.89M)(24.93M)(25.24M)[{"date":"2019-12-31","value":-767531200,"profit":false},{"date":"2020-12-31","value":-913512600,"profit":false},{"date":"2021-12-31","value":-1689250300,"profit":false},{"date":"2022-12-31","value":-2493200000,"profit":false},{"date":"2023-12-31","value":-2523800000,"profit":false}]
Total Non-Operating Income/Expense99.83K3.38K383.39K424.00K1.89M[{"date":"2019-12-31","value":5.27,"profit":true},{"date":"2020-12-31","value":0.18,"profit":true},{"date":"2021-12-31","value":20.24,"profit":true},{"date":"2022-12-31","value":22.39,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(7.63M)(9.14M)(16.53M)(24.67M)(23.52M)[{"date":"2019-12-31","value":-762539700,"profit":false},{"date":"2020-12-31","value":-913548600,"profit":false},{"date":"2021-12-31","value":-1652782200,"profit":false},{"date":"2022-12-31","value":-2466900000,"profit":false},{"date":"2023-12-31","value":-2351600000,"profit":false}]
Income Taxes588.82K(215.55K)(331.41K)(365.00K)-[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-36.61,"profit":false},{"date":"2021-12-31","value":-56.28,"profit":false},{"date":"2022-12-31","value":-61.99,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(8.21M)(8.92M)(16.20M)(24.30M)-[{"date":"2019-12-31","value":-821421900,"profit":false},{"date":"2020-12-31","value":-891994000,"profit":false},{"date":"2021-12-31","value":-1619641300,"profit":false},{"date":"2022-12-31","value":-2430400000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(7.63M)(9.14M)(16.53M)(24.67M)(24.05M)[{"date":"2019-12-31","value":-762539700,"profit":false},{"date":"2020-12-31","value":-913548600,"profit":false},{"date":"2021-12-31","value":-1652782200,"profit":false},{"date":"2022-12-31","value":-2466900000,"profit":false},{"date":"2023-12-31","value":-2404700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(7.63M)(8.92M)(16.20M)(24.30M)(23.52M)[{"date":"2019-12-31","value":-762539700,"profit":false},{"date":"2020-12-31","value":-891994000,"profit":false},{"date":"2021-12-31","value":-1619641300,"profit":false},{"date":"2022-12-31","value":-2430400000,"profit":false},{"date":"2023-12-31","value":-2351600000,"profit":false}]
EPS (Diluted)(6.01)(3.85)(1.96)(2.19)(1.96)[{"date":"2019-12-31","value":-601,"profit":false},{"date":"2020-12-31","value":-385,"profit":false},{"date":"2021-12-31","value":-196,"profit":false},{"date":"2022-12-31","value":-219,"profit":false},{"date":"2023-12-31","value":-196,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

NVNO
Cash Ratio 21.70
Current Ratio 22.01

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NVNO
ROA (LTM) -37.28%
ROE (LTM) -58.77%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NVNO
Debt Ratio Lower is generally better. Negative is bad. 0.06
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.94

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NVNO
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.93
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is enVVeno Medical Corp share price today?

enVVeno Medical Corp (NVNO) share price today is $2.49

Can Indians buy enVVeno Medical Corp shares?

Yes, Indians can buy shares of enVVeno Medical Corp (NVNO) on Vested. To buy enVVeno Medical Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NVNO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of enVVeno Medical Corp be purchased?

Yes, you can purchase fractional shares of enVVeno Medical Corp (NVNO) via the Vested app. You can start investing in enVVeno Medical Corp (NVNO) with a minimum investment of $1.

How to invest in enVVeno Medical Corp shares from India?

You can invest in shares of enVVeno Medical Corp (NVNO) via Vested in three simple steps:

  • Click on Sign Up or Invest in NVNO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in enVVeno Medical Corp shares
What is enVVeno Medical Corp 52-week high and low stock price?

The 52-week high price of enVVeno Medical Corp (NVNO) is $6.97. The 52-week low price of enVVeno Medical Corp (NVNO) is $2.45.

What is enVVeno Medical Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of enVVeno Medical Corp (NVNO) is

What is enVVeno Medical Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of enVVeno Medical Corp (NVNO) is 0.93

What is enVVeno Medical Corp dividend yield?

The dividend yield of enVVeno Medical Corp (NVNO) is 0.00%

What is the Market Cap of enVVeno Medical Corp?

The market capitalization of enVVeno Medical Corp (NVNO) is $44.37M

What is enVVeno Medical Corp’s stock symbol?

The stock symbol (or ticker) of enVVeno Medical Corp is NVNO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top